Oric Pharmaceuticals, Inc. (ORIC)
Oric Pharmaceuticals, Inc. filed 13 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 19 transactions and 466,800 shares. None carries the SEC's AFF10B5ONE flag; all 13 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-28, came 31 days after the one before it (2026-07-28) and reports 5 transactions against 4 in the filing before it.
- The sales it reports total 77,000 shares, 63,900 more than the 13,100 in the filing before it.
- Its 13 plan statements rank 351st of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 13 filings on file run from 2025-06-09 to 2026-08-28, and state 4 plan adoption dates, from 2024-12-30 to 2026-05-26.
Trades in Oric Pharmaceuticals, Inc. 19
- Piscitelli Dominic — 2025-06-06 · S · 2,600 shares
- Piscitelli Dominic — 2025-06-09 · S · 300 shares
- Piscitelli Dominic — 2025-06-12 · S · 300 shares
- Piscitelli Dominic — 2025-06-23 · S · 584 shares
- Piscitelli Dominic — 2025-06-23 · S · 450 shares
- Piscitelli Dominic — 2025-06-24 · S · 32,466 shares
- Piscitelli Dominic — 2025-07-01 · S · 20,000 shares
- Chacko Jacob — 2025-09-22 · S · 125,000 shares
- Chacko Jacob — 2025-09-30 · S · 34,538 shares
- Chacko Jacob — 2025-10-01 · S · 53,001 shares
- Chacko Jacob — 2025-10-06 · S · 37,461 shares
- Piscitelli Dominic — 2025-10-06 · S · 11,000 shares
Adoption dates in Oric Pharmaceuticals, Inc. 4
- 2024-12-30 — stated in 4 filings
- 2025-06-21 — stated in 3 filings
- 2025-06-24 — stated in 2 filings
- 2026-05-26 — stated in 1 filing
Results prints in Oric Pharmaceuticals, Inc. 7
- 2025-02-18
- 2025-05-05
- 2025-08-12
- 2025-11-13
- 2026-02-23
- 2026-05-04
- 2026-08-03
Trades before a print in Oric Pharmaceuticals, Inc. 0
- 10 days before the 2026-08-03 print — 2026-07-24 · S · Heyman Richard A. · 7,000 shares
- 10 days before the 2026-08-03 print — 2026-07-24 · S · Heyman Richard A. · 6,100 shares
- 28 days before the 2026-08-03 print — 2026-07-06 · S · Heyman Richard A. · 300 shares
- 38 days before the 2025-11-13 print — 2025-10-06 · S · Chacko Jacob · 37,461 shares
- 38 days before the 2025-11-13 print — 2025-10-06 · S · Piscitelli Dominic · 11,000 shares
- 38 days before the 2026-02-23 print — 2026-01-16 · S · Heyman Richard A. · 3,500 shares
- 38 days before the 2026-02-23 print — 2026-01-16 · S · Heyman Richard A. · 3,200 shares
- 42 days before the 2025-08-12 print — 2025-07-01 · S · Piscitelli Dominic · 20,000 shares
- 43 days before the 2025-11-13 print — 2025-10-01 · S · Chacko Jacob · 53,001 shares
- 44 days before the 2025-11-13 print — 2025-09-30 · S · Chacko Jacob · 34,538 shares
- 49 days before the 2025-08-12 print — 2025-06-24 · S · Piscitelli Dominic · 32,466 shares
- 50 days before the 2025-08-12 print — 2025-06-23 · S · Piscitelli Dominic · 584 shares
Interval to Oric Pharmaceuticals, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 2within 10 days
- 10shortest, days
- 1no later print
- Heyman Richard A. 2026-07-24 · S · 10 days before the 2026-08-03 print
- Heyman Richard A. 2026-07-24 · S · 10 days before the 2026-08-03 print
Adoption dates Oric Pharmaceuticals, Inc. states
- 2024-12-30 in 4 filings
- 2025-06-21 in 3 filings
- 2025-06-24 in 2 filings
- 2026-05-26 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Reporting Person on December 30, 2024”
Reported results dates on file
- 2025-02-18
- 2025-05-05
- 2025-08-12
- 2025-11-13
- 2026-02-23
- 2026-05-04
- 2026-08-03
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.
The address of this record
Oric Pharmaceuticals, Inc.’s insider trading plan record — 13 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001796280.